| HGNC Family | Non-coding RNAs |
| Name | microRNA 3178 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nmiR-3178 has emerged as a tumor‐suppressive microRNA in several human cancers. In triple‐negative breast cancer, miR-3178 is markedly downregulated, with its low expression correlating with poor overall survival; its restoration suppresses cell proliferation, invasion, and migration by inhibiting the epithelial-to-mesenchymal transition via direct targeting of Notch1. Similarly, in hepatocellular carcinoma (HCC) tumor endothelial cells, reduced miR-3178 levels are associated with enhanced proliferation, invasion, migration, and angiogenesis, while overexpression of miR-3178 inhibits these malignant behaviors by downregulating its target, early growth response gene 3 (EGR3). Moreover, in H. pylori-positive gastric tissues, decreased miR-3178 expression coincides with upregulation of TRAF3 and aberrant NF-κB signaling, suggesting an involvement in modulating inflammation-related carcinogenic pathways."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistically, miR-3178 exerts its regulatory effects via multiple oncogenic pathways. mTOR signaling has been shown to suppress miR-3178, resulting in the upregulation of CDC6—a key factor in DNA replication licensing that contributes to unchecked cell cycle progression. In addition, treatment with baicalein increases miR-3178 levels in HCC cells, leading to diminished expression of histone deacetylase 10 (HDAC10) and subsequent inactivation of signaling pathways such as AKT/MDM2/p53/Bcl2/Bax and FoxO3α/p27/CDK2/Cyclin E1 that are critical for cell survival and growth. These findings underscore the role of miR-3178 as a pivotal regulator of cell cycle and survival signals in oncogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCollectively, these studies highlight the multifaceted functions of miR-3178 as a suppressor of tumor progression through its direct targeting of key genes involved in metastasis, cell proliferation, and inflammatory signaling. Modulation of miR-3178—either by restoring its diminished expression in cancerous tissues or by counteracting the pathways that suppress it—represents a promising therapeutic strategy across diverse malignant contexts."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Wei Li, Shiqiang Shen, Shanmin Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2015.07.057"}], "href": "https://doi.org/10.1016/j.bbrc.2015.07.057"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26182877"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26182877"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Meijuan Zou, Fang Wang, Aiqin Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-3178 ameliorates inflammation and gastric carcinogenesis promoted by Helicobacter pylori new toxin, Tip-α, by targeting TRAF3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Helicobacter (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/hel.12348"}], "href": "https://doi.org/10.1111/hel.12348"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27493095"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27493095"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Peng Kong, Lie Chen, Muxin Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-018-1091-y"}], "href": "https://doi.org/10.1038/s41419-018-1091-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30333478"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30333478"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xianjin Wu, Shenghua Li, Xing Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "mTOR Signaling Upregulates CDC6 via Suppressing miR-3178 and Promotes the Loading of DNA Replication Helicase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-019-46052-8"}], "href": "https://doi.org/10.1038/s41598-019-46052-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31285446"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31285446"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Junan Qi, Jun Li, Beibei Bie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-3,178 contributes to the therapeutic action of baicalein against hepatocellular carcinoma cells via modulating HDAC10."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Phytother Res (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ptr.7613"}], "href": "https://doi.org/10.1002/ptr.7613"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36070933"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36070933"}]}]}]}
|
| Synonyms | MIR-3178 |
| NCBI Gene ID | 100422974 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR3178 has 1,113 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 11 datasets.
Click the + buttons to view associations for MIR3178 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR3178 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR3178 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR3178 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR3178 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR3178 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR3178 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR3178 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MIR3178 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR3178 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR3178 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR3178 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |